Plain-English translation of NCT07421700 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This clinical trial is testing a new drug called to see if it can help people with advanced bladder cancer that has spread to nearby tissues or other parts of the body. The study will look at whether this medication is safe, how well it works, and how it moves through your body. Some participants will receive the medication alone, while others will receive it combined with another cancer drug called .
Advanced bladder cancer is a serious condition, and doctors are looking for new treatment options that might work better or be easier to tolerate than current choices. This trial will help determine whether this new medication could offer hope to patients who need effective new therapies.
You likely qualify if…
You likely don't qualify if…
You will attend regular clinic visits to receive the study medication through an IV infusion (into your vein). You will have blood tests, physical exams, and imaging scans (like CT scans) to check how your cancer is responding and monitor for any side effects. Your treatment will continue as long as it appears to be helping and side effects remain manageable. The total duration will depend on how you respond and how well you tolerate the medication.
AI-generated summary from trial data · Aug 19, 2026 · Not medical advice
United States